ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 852

Systemic Lupus Erythematosous and Primary Sjogren’s Syndrome May Display Joint Erosions On MRI As Well As Healthy Control, But Cannot Be Considered As Erosive Disease Such As Rheumatoid Arthritis: : An MRI Observational Study Of 90 Subjects

Frédérique Gandjbakhch1, Violaine Foltz2, Jérôme Renoux3, Nahalie Cozic4, Nathalie Costedoat-Chalumeau5, Damien Sene6, Guillaume Mercy7, Zahir Amoura8, Jean-Charles Piette9, Nathalie Morel10, Pierre Bourgeois11 and Bruno Fautrel12, 1Department of Rheumatology, APHP, Pitié Salpétrière Hospital, Universite Paris 6, Paris, France, 2APHP, Pitié Salpétrière Hospital, Universite Paris 6, Paris, France, 3Radiology, Pitie-Salpetriere Hospital, Paris, France, 4APHP, Pitie Salpetriere Hospital, department of statistics, Paris, France, 5Internal Medicine, Hopital Cochin, Paris, France, 6Internal Medicine, Hopital Lariboisière, Paris, France, 7APHP, Pitie-Salpétrière Hospital, paris, France, 8Department of Internal Medicine 2. Referal center for SLE/APS, CHU Pitié-Salpêtrière, Paris, France, 9Department of Internal Medicine 1., CHU Pitié-Salpêtrière, Paris, France, 10Internal Medicine, Groupe Hospitalier Pitié-Salpétrière, Paris, France, 11Rheumatology, APHP,Pitie-Salpetriere Hospital, Paris 6, Paris, France, 12Paris 6 – Pierre et Marie Curie University; AP-HP, Rheumatology, Pitié-Salpêtrière Hospital, - GRC-UPMC 08 – EEMOIS, Paris, France

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Lupus, MRI, Sjogren's syndrome and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Imaging of Rheumatic Diseases: Imaging in Vascular and Extra-articular

Session Type: Abstract Submissions (ACR)

Background/Purpose: Recent studies tend to demonstrate presence of MRI erosion in Systemic Lupus Erythematosous (SLE) and primary Sjogren’s syndrome (pSS). The objective of this study was to describe MRI characteristics (erosion and osteitis, i.e. bone marrow oedema) of patients with SLE and pSS without association with rheumatoid arthritis (RA) compared to “positive control”,i.e. RA and “negative control” (sex/age- matched healthy controls ).

Methods: pSS, SLE, RA  and HC were prospectively included from 2 university departments (rheumatology and internal medicine) between 2009 and 2011. Inclusion criteria were: 1- for lupus and primary SS : disease duration >2 years, no association with RA  defined as no arthritis, no ACPA, normal X rays of hand and feet. 2-for Healthy controls (HC): no history of tender or swollen joint or rheumatic disease. 3- for RA: established RA with duration>2 years. MRI of MCP2 to 5 and wrist of the dominant hand was performed for all subjects using a dedicated MRI (ESAOTE Cscan 0.2 Tesla) in coronal and axial plans using T1 and STIR sequences, without gadolinium injection, in order to evaluate erosion and osteitis according to the OMERACT definitions. Adaptation of the OMERACT definition for erosion was used in order to differenciate physiological cortical break,i.e. vascular foramen and erosion due to pathological process. MRIs were evaluated by 2 independent readers, blindly to clinical and radiographic data using RAMRIS scores for erosion and osteitis. Statistics were performed using SAS 9.3 software.

Results: 90 subjects were included prospectively in the study: 19 pSS, 21 SLE, 30 RA and 20 HC. 83 % of  RA patients were erosive on Xrays, 86%  and 72 % were RF and ACPA positive. All SLE and pSS patients had normal Xrays of hand and feet (inclusion criteria). All patients and HC had at least one cortical break seen in 2 plans on MRI of hand and wrist without statistical difference between the groups. Frequencies and scores for erosion and for osteitis were statistically different between RA and SLE/pSS while no statistical difference was seen between SLE/pSS and HC (Table). Sensitivity and specificity were respectively for erosion: 0.93 and 0.38, for erosion with grade ≥2: 0.4 and 0.88 and for osteitis: 0.77 and 0.78. A cut-off of RAMRIS erosion was determined at 9 and could discriminate SLE/pss and RA patients (AUC= 0.8007) with good sensitivity (0.68) and specificity (0.84).Erosions in wrist and MCP3 were frequent in all groups, while erosions in MCP2, MCP4 and MCP5 were more frequently observed in RA with statistical difference between the groups.

 

RA

(n=30)

Lupus (n=21)

SS

(n=19)

HC

(n=20)

SLE /pSS vs RA

SLE / pSS vs HC

Patient with at least one Cortical break, n(%)

30(100%)

21(100%)

19(100%)

20(100%)

NS

NS

Patient with at least one erosion, n(%)

28(93%)

12(57%)

13(68%)

12(60%)

0.004

1

Patient with at least one erosion ≥grade2, n(%)

22(69%)

9(43%)

7(36%)

5 (25%)

0.019

0.39

Patient with at least one osteitis, n(%)

23(77%)

3(14%)

5(26%)

5(25%)

<.0001

0.74

Patient with at least one erosion and one osteitis, n(%)

22(69%)

3(14%)

5(26%)

5(25%)

<.0001

0.74

RAMRISerosion

21.6±10.34 

13.02±5.59

11.56±5.73

10.69±4.54

0.0003

0.40

RAMRISosteitis

2.29±4.69

0.17±0.67

0.11±0.27

0.29±0.79

0.0005

0.63

Conclusion: MRI Cortical break are frequent in SLE and pSS as well as in HC. Erosions may be seen in SLE and pSS but can be distinguished from erosions of RA. Distinction of physiological cortical break and pathological erosion may lead to better interpretation of MRI and further consensus on MRI definition of these 2 items should be to consider.


Disclosure:

F. Gandjbakhch,
None;

V. Foltz,
None;

J. Renoux,
None;

N. Cozic,
None;

N. Costedoat-Chalumeau,
None;

D. Sene,
None;

G. Mercy,
None;

Z. Amoura,
None;

J. C. Piette,
None;

N. Morel,
None;

P. Bourgeois,
None;

B. Fautrel,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/systemic-lupus-erythematosous-and-primary-sjogrens-syndrome-may-display-joint-erosions-on-mri-as-well-as-healthy-control-but-cannot-be-considered-as-erosive-disease-such-as-rheumatoid-arthri/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology